Menopause management got a nuanced update at the Royal College of Physicians of Edinburgh's "Modern Medicine: Menopause" lecture, where specialists Claire Phipps and Sarah Glynne made one thing clear: there's no universal playbook for HRT. With at least 75% of women experiencing menopausal symptoms and about 25% seeking medical help, the experts emphasized that care is still falling short — some symptoms are dismissed, others are over-attributed to menopause without proper evaluation.

The recommended approach starts with lifestyle: regular physical activity (including strength training and yoga), a calcium-rich diet, good sleep hygiene, and cutting back on alcohol and spicy foods. When medication is needed, HRT remains the most effective option for hormone-deficiency symptoms, but the route matters — transdermal oestrogen (patches, gels, sprays) does not raise thrombosis risk the way oral oestrogen does. Non-hormonal options like venlafaxine and menopause-specific cognitive behavioural therapy can also play a role.

Key Takeaways:

• Perimenopause is a clinical diagnosis — a single hormone test cannot confirm or rule it out
• HRT can reduce osteoporosis risk by 30–40%, but the protective effect fades quickly after stopping
• Starting HRT within 10 years of menopause or before age 60 may be linked to lower cardiovascular risk
• Oestrogen-only therapy post-hysterectomy was associated with lower breast cancer risk than placebo in the Women's Health Initiative
• No professional association recommends a fixed time limit for HRT — decisions should be guided by ongoing benefits, risks, and tolerability

Why it matters: With millions of women navigating menopause, clinicians need individualized, evidence-based frameworks — not blanket rules — to provide effective, safe, and compassionate care.